옵토제네틱스 시장 : 광기기, 액추에이터, 센서, 용도별 - 세계 예측(2025-2030년)

The Optogenetics Market was valued at USD 588.56 million in 2023, expected to reach USD 617.96 million in 2024, and is projected to grow at a CAGR of 5.39%, to USD 850.02 million by 2030.

Optogenetics is a cutting-edge biological technique that combines genetic and optical methods to precisely control and monitor the activities of individual neurons in living tissue. The necessity of optogenetics arises from its ability to provide high spatial and temporal resolution in manipulating neuronal activity, which is invaluable for understanding complex neural circuits and treating neurological disorders. Its applications extend to neuroscience research, treatment of vision and hearing impairments, and mental health therapies. End-use scopes include academic research, medical diagnostics, and therapeutic applications, highlighting its significance in both clinical settings and advanced neurobiological studies.

Key growth factors in the optogenetics market include the expanding neuroscience research field, increasing investments in biotechnology, and advancements in light-activated proteins and optogenetic tools. The latest potential opportunities lie in the development of wireless optogenetics systems and integration with other technologies like CRISPR for enhanced gene modulation. Companies are recommended to focus on partnerships with research institutions, invest in miniaturized and wireless device innovations, and explore interdisciplinary applications with artificial intelligence for real-time data analysis. However, growth limitations include technical challenges in light delivery to deep brain tissues, ethical considerations in genetic modifications, and high initial costs for setup.

The market also faces restrictions from strict regulatory environments and the need for skilled personnel, potentially hindering rapid adoption. Despite these challenges, areas vibrant with innovation potential include the development of non-invasive optogenetic technology, such as transcranial magnetic stimulation combined with optogenetic methods, and exploring optogenetics in non-neuroscientific applications like cardiac research for understanding arrhythmias. The market dynamics suggest a promising upward trajectory, with ongoing research poised to overcome existing hurdles. To thrive, companies should prioritize innovation in user-friendly, cost-effective technologies and form strategic alliances to expand applications beyond traditional neuroscience domains.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Optogenetics Market

The Optogenetics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising cases of neurological disorders
  • Increasing need as a diagnostic tool in neurosciences
  • Growing adoption of multimodal imaging technologies
• Market Restraints
  • High cost of optogenetics
• Market Opportunities
  • Ongoing research and development for optogenetics solutions
  • Potential demand to treat depression symptoms
• Market Challenges
  • Lack of awareness towards optogenetics

Porter's Five Forces: A Strategic Tool for Navigating the Optogenetics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Optogenetics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Optogenetics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Optogenetics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Optogenetics Market

A detailed market share analysis in the Optogenetics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Optogenetics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Optogenetics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Optogenetics Market

A strategic analysis of the Optogenetics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Optogenetics Market, highlighting leading vendors and their innovative profiles. These include Applied Genetic Technologies Corporation, Elliot Scientific Ltd., Gensight Biologics S.A., HUBNER GmbH & Co. KG, Kubota Pharmaceutical Holdings Co., Ltd., Laserglow Technologies, MapLight Therapeutics, Inc., Merck KGaA, Nanoscope Technologies LLC, Noldus Information Technology BV, Opto biolabs GmbH, Prizmatix Ltd., Ray Therapeutics, Scientifica Ltd., and Shanghai Laser & Optics Century Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Optogenetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Light Equipment, market is studied across Laser and Light-Emitting Diode.
• Based on Actuator, market is studied across Archaerhodopsin, Channelrhodopsin, and Halorhodopsin.
• Based on Sensor, market is studied across Aequorin, Calcium, Cameleon, Chloride, and Membrane-Gated (Mermaid).
• Based on Application, market is studied across Behavioral Tracking, Disease Treatment, Neuroscience, and Retinal.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising cases of neurological disorders
    • 5.1.1.2. Increasing need as a diagnostic tool in neurosciences
    • 5.1.1.3. Growing adoption of multimodal imaging technologies
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of optogenetics
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development for optogenetics solutions
    • 5.1.3.2. Potential demand to treat depression symptoms
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of awareness towards optogenetics
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Optogenetics Market, by Light Equipment

• 6.1. Introduction
• 6.2. Laser
• 6.3. Light-Emitting Diode

7. Optogenetics Market, by Actuator

• 7.1. Introduction
• 7.2. Archaerhodopsin
• 7.3. Channelrhodopsin
• 7.4. Halorhodopsin

8. Optogenetics Market, by Sensor

• 8.1. Introduction
• 8.2. Aequorin
• 8.3. Calcium
• 8.4. Cameleon
• 8.5. Chloride
• 8.6. Membrane-Gated (Mermaid)

9. Optogenetics Market, by Application

• 9.1. Introduction
• 9.2. Behavioral Tracking
• 9.3. Disease Treatment
• 9.4. Neuroscience
• 9.5. Retinal

10. Americas Optogenetics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Optogenetics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Optogenetics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Applied Genetic Technologies Corporation
• 2. Elliot Scientific Ltd.
• 3. Gensight Biologics S.A.
• 4. HUBNER GmbH & Co. KG
• 5. Kubota Pharmaceutical Holdings Co., Ltd.
• 6. Laserglow Technologies
• 7. MapLight Therapeutics, Inc.
• 8. Merck KGaA
• 9. Nanoscope Technologies LLC
• 10. Noldus Information Technology BV
• 11. Opto biolabs GmbH
• 12. Prizmatix Ltd.
• 13. Ray Therapeutics
• 14. Scientifica Ltd.
• 15. Shanghai Laser & Optics Century Co., Ltd.